Literature DB >> 29913011

Anti-Myelin Oligodendrocyte Glycoprotein Antibody-Associated Central Nervous System Demyelination-A Novel Disease Entity?

Martin S Weber1,2, Tobias Derfuss3,4, Wolfgang Brück1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29913011     DOI: 10.1001/jamaneurol.2018.1055

Source DB:  PubMed          Journal:  JAMA Neurol        ISSN: 2168-6149            Impact factor:   18.302


× No keyword cloud information.
  8 in total

Review 1.  Monoclonal Antibody Therapies Beyond Complement for NMOSD and MOGAD.

Authors:  Vyanka Redenbaugh; Eoin P Flanagan
Journal:  Neurotherapeutics       Date:  2022-03-10       Impact factor: 6.088

2.  Anti-myelin oligodendrocyte glycoprotein antibodies in a girl with good recovery after five episodes of prior idiopathic optic neuritis.

Authors:  Mathias Falck Schmidt; Gorm Pihl-Jensen; Margrethe Bastholm Bille; Jette Lautrup Frederiksen
Journal:  Am J Ophthalmol Case Rep       Date:  2021-03-24

3.  Comparative Analysis of T-Cell Responses to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in Inflammatory Demyelinating Central Nervous System Diseases.

Authors:  Livia Sophie Hofer; Melanie Ramberger; Viktoria Gredler; Anna Sophie Pescoller; Kevin Rostásy; Mireia Sospedra; Harald Hegen; Thomas Berger; Andreas Lutterotti; Markus Reindl
Journal:  Front Immunol       Date:  2020-06-17       Impact factor: 7.561

Review 4.  The Role of B Cells and Antibodies in Multiple Sclerosis, Neuromyelitis Optica, and Related Disorders.

Authors:  Silke Häusser-Kinzel; Martin S Weber
Journal:  Front Immunol       Date:  2019-02-08       Impact factor: 7.561

5.  Natalizumab promotes activation and pro-inflammatory differentiation of peripheral B cells in multiple sclerosis patients.

Authors:  Jan W Traub; Hannah L Pellkofer; Katja Grondey; Ira Seeger; Christoph Rowold; Wolfgang Brück; Leila Husseini; Silke Häusser-Kinzel; Martin S Weber
Journal:  J Neuroinflammation       Date:  2019-11-16       Impact factor: 8.322

Review 6.  Molecular biomarkers in multiple sclerosis.

Authors:  Tjalf Ziemssen; Katja Akgün; Wolfgang Brück
Journal:  J Neuroinflammation       Date:  2019-12-23       Impact factor: 8.322

7.  A highly specific and sensitive nanoimmunosensor for the diagnosis of neuromyelitis optica spectrum disorders.

Authors:  Ariana de Souza Moraes; Doralina Guimarães Brum; Jéssica Cristiane Magalhães Ierich; Akemi Martins Higa; Amanda Stefanie Jabur Assis; Celina Massumi Miyazaki; Flávio Makoto Shimizu; Luís Antonio Peroni; M Teresa Machini; Amilton Antunes Barreira; Marystela Ferreira; Osvaldo N Oliveira; Fabio Lima Leite
Journal:  Sci Rep       Date:  2019-11-06       Impact factor: 4.379

Review 8.  B Cells and Antibodies as Targets of Therapeutic Intervention in Neuromyelitis Optica Spectrum Disorders.

Authors:  Jan Traub; Leila Husseini; Martin S Weber
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.